Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Oxford Cancer Biomarkers Ltd.

Oxford Cancer Biomarkers translates ground-breaking scientific discovery into predictive biomarker diagnostic products that allow medicines to be personalised for the benefit of the cancer patient. Oxford Cancer Biomarkers is a spin-out of the University of Oxford and has strong links with the Medical Sciences Division in Oxford University. The company was founded by Nick La Thangue, Ph.D., Chair of Cancer Biology at Oxford University and David Kerr, CBE, D.Sc., M.D. FMedSci, Professor of Cancer Medicine at Oxford University. Investors in OCB include Longwall Venture Partners LLP, Esperante BV and the University. *

 

Period Start 2012-01-18 splitoff
  Group Iqvia (Group)
  Predecessor University of Oxford
Products Industry biomarker
  Industry 2 oncology
Persons Person Browning, David (Oxford Cancer Biomarker 201901 CEO + OBN Board Member before BioCity/MediCity + Philips + Amersham)
  Person 2 Sblendorio, Glenn (The Medicines Co 200603 CFO before Eyetech Pharma)
     
Region Region Oxford, Oxfordshire
  Country United Kingdom (GB)
  Street Robert Robinson Avenue
Oxford Science Park, Magdalen Centre
  City OX4 4GA Oxford, Oxfordshire
  Tel +44-1865-784743
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: Oxford Cancer Biomarkers Ltd.. (4/19/17). "Press Release: Oxford Cancer Biomarkers Announces Strategic Collaboration with My-BioMed Biotechnology Co. Ltd.". Oxford.
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Iqvia (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top